Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort-Reference-Cited by-同舟云学术

Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort

Published:2018-04-10 Issue:1 Volume:63 Page:373-381
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Niemantsverdriet Ellis¹,Feyen Bart F.E.¹²,Le Bastard Nathalie¹³,Martin Jean-Jacques¹,Goeman Johan⁴,De Deyn Peter Paul¹⁴,Bjerke Maria¹,Engelborghs Sebastiaan¹⁴

Affiliation:

1. Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, and Biobank, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium

2. Current affiliation: Department of Neurosurgery, University Hospital Antwerp, Edegem, Belgium

3. Current affiliation: Fujirebio Europe, Ghent, Belgium

4. Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference34 articles.

1. Overdiagnosing vascular dementia using structural brain imaging for dementia work-up;Niemantsverdriet;J Alzheimers Dis,2015

2. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia;Engelborghs;Neurobiol Aging,2008

3. Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: A follow-up study;Hansson;Lancet Neurol,2006

4. A decade of cerebrospinal fluid biomarkers for Alzheimer’s disease in Belgium;Somers;J Alzheimers Dis,2016

5. Amyloid pathology influences abeta1-42 cerebrospinal fluid levels in dementia with lewy bodies;Slaets;J Alzheimers Dis,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personal value of Alzheimer's disease biomarker testing and result disclosure from the patient and care partner perspective;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2024-04

2. Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology;Clinical Chemistry;2023-09-19

3. Cerebrospinal fluid: A specific biofluid for the biosensing of Alzheimer's diseases biomarkers;TrAC Trends in Analytical Chemistry;2023-09

4. Study of Alzheimer's disease- and frontotemporal dementia-associated genes in the Cretan Aging Cohort;Neurobiology of Aging;2023-03

5. Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2022-01